DANIEL BARRON: Open Payments
NPI 1487951844 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,918 in 154 payments from 22 companies in 2025. Trend: 2023 $2,710 · 2024 $4,250 · 2025 $3,918
Food & beverage: $3,723Education: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $508 |
| Arcutis Biotherapeutics, Inc. | 18 | $479 |
| UCB, Inc. | 8 | $362 |
| MERZ NORTH AMERICA, INC. | 2 | $360 |
| Janssen Biotech, Inc. | 18 | $331 |
| Novartis Pharmaceuticals Corporation | 15 | $326 |
| Galderma Laboratories, L.P. | 17 | $323 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $294 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 15 | $154 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
Products named: Zoryve, Bimzelx, Xeomin, TREMFYA, NEMLUVIO, COSENTYX, BOTOX, ILUMYA.
Industry payments across TX — which companies pay providers there.
